- TUDORZA PRESSAIR (aclidinium bromide inhalation powder) Prescribing Information. Forest Pharmaceuticals, Inc. St. Louis, MO
- Data on file. Forest Laboratories, Inc.
- Kerwin EM, D’Urzo AD, Gelb AF, et al, on behalf of the ACCORD 1 study investigators. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD. 2012;9:90-101.